1-8 of 8
Günter Henze
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bilateral Involvement Is an Independent Risk Factor in Testicular Relapse of Childhood ALL: Results of the Trials ALL-REZ BFM 83 - 2002

Christiane Chen-Santel, MD, Ulrike Tabien, MD, Claudia van Schewick, MD, Martin Schrappe, MD, Gabriele Escherich, MD, Angelika Eggert, MD, Günter Henze, MD, Arend Stackelberg, MD, Patrick Hundsdörfer, MD
Journal: Blood
Blood (2014) 124 (21): 66.
https://doi.org/10.1182/blood.V124.21.66.66
Published: 2014
Journal Articles

Anti– Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials

Clinical Trials & Observations
Andrea Willer, Joachim Gerß, Thorsten König, Dieter Franke, Hans-Jürgen Kühnel, Günter Henze, Arendt von Stackelberg, Anja Möricke, Martin Schrappe, Joachim Boos, Claudia Lanvers-Kaminsky
Journal: Blood
Blood (2011) 118 (22): 5774–5782.
https://doi.org/10.1182/blood-2011-07-367904
Published: 2011
Includes: Supplemental data
Journal Articles

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

CME
Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi, André Schrauder, Renate Panzer-Grümayer, Anja Möricke, Maurizio Aricò, Martin Zimmermann, Georg Mann, Giulio De Rossi, Martin Stanulla, Franco Locatelli, Giuseppe Basso, Felix Niggli, Elena Barisone, Günter Henze, Wolf-Dieter Ludwig, Oskar A. Haas, Giovanni Cazzaniga, Rolf Koehler, Daniela Silvestri, Jutta Bradtke, Rosanna Parasole, Rita Beier, Jacques J. M. van Dongen, Andrea Biondi, Martin Schrappe
Journal: Blood
Blood (2010) 115 (16): 3206–3214.
https://doi.org/10.1182/blood-2009-10-248146
Published: 2010
Includes: Supplemental data
Journal Articles

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Clinical Trials & Observations
Anja Möricke, Alfred Reiter, Martin Zimmermann, Helmut Gadner, Martin Stanulla, Michael Dördelmann, Lutz Löning, Rita Beier, Wolf-Dieter Ludwig, Richard Ratei, Jochen Harbott, Joachim Boos, Georg Mann, Felix Niggli, Andreas Feldges, Günter Henze, Karl Welte, Jörn-Dirk Beck, Thomas Klingebiel, Charlotte Niemeyer, Felix Zintl, Udo Bode, Christian Urban, Helmut Wehinger, Dietrich Niethammer, Hansjörg Riehm, Martin Schrappe
Journal: Blood
Blood (2008) 111 (9): 4477–4489.
https://doi.org/10.1182/blood-2007-09-112920
Published: 2008
Includes: Supplemental data
Journal Articles

High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia

Clinical Trials & Observations
Arend von Stackelberg, Reinhard Hartmann, Christoph Bührer, Rüdiger Fengler, Gritta Janka-Schaub, Alfred Reiter, Georg Mann, Kjeld Schmiegelow, Richard Ratei, Thomas Klingebiel, Jörg Ritter, Günter Henze
Journal: Blood
Blood (2008) 111 (5): 2573–2580.
https://doi.org/10.1182/blood-2007-07-102525
Published: 2008
Journal Articles

Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group

Nikola Hagedorn, Cécile Acquaviva, Eva Fronkova, Arend von Stackelberg, Andrea Barth, Udo zur Stadt, André Schrauder, Jan Trka, Nathalie Gaspar, Karl Seeger, Günter Henze, Hélène Cavé, Cornelia Eckert
Journal: Blood
Blood (2007) 110 (12): 4022–4029.
https://doi.org/10.1182/blood-2007-04-082040
Published: 2007
Includes: Supplemental data
Journal Articles

A European Phase II Study (BIOV-111) of Clofarabine (Evoltra®) in Refractory and Relapsed Childhood Acute Lymphoblastic Leukemia: Final Results.

Pamela Kearns, MD, PhD, Gerard Michel, MD, Brigitte Nelken, MD, Simon Joel, PhD, Essam Al-Ghazaly, PhD, Auke Beishuizen, MD, PhD, Valentino Conter, MD, Gunter Henze, MD, Andre Baruchel, MD, Vaskar Saha, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 11.
https://doi.org/10.1182/blood.V110.11.11.11
Published: 2007
Journal Articles

BIOV-111 a European Phase II Trial of Clofarabine (Evoltra ® ) in Refractory and Relapsed Childhood Acute Lymphoblastic Leukemia.

Pamela Kearns, MD,PhD, Gerard Michel, MD, Brigitte Nelken, MD, Simon Joel, PhD, Essam Al-Ghazaly, MD, Auke Beishuizen, MD,PhD, Valentino Conter, MD, Helmut Gadner, MD, Gunter Henze, MD, Hazel Smith, PhD, Andre Baruchel, MD, Vaskar Saha, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 1859.
https://doi.org/10.1182/blood.V108.11.1859.1859
Published: 2006